NCT04074551View on ClinicalTrials.gov

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

March 17, 2020

Study Completion Date

March 17, 2020

Conditions
HypertensionDyslipidemias
Interventions
DRUG

HCP1701

HCP1701

DRUG

Losartan

Losartan

DRUG

Amlodipine

Amlodipine

DRUG

Rosuvastatin and Ezetimibe

Rosuvastatin and Ezetimibe

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04074551 - A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia | Biotech Hunter | Biotech Hunter